98 related articles for article (PubMed ID: 17921711)
1. The use of radiolabeled somatostatin analog scintigraphy in the staging of small cell lung cancer patients.
Tzannou IA; Karapanagiotou EM; Charpidou A; Dilana K; Alamara C; Christakopoulou I; Georgiou E; Syrigos KN
Am J Clin Oncol; 2007 Oct; 30(5):503-6. PubMed ID: 17921711
[TBL] [Abstract][Full Text] [Related]
2. [Diagnostic value of somatostatin receptor scintigraphy with indium-111 pentetreotide in small-cell bronchial carcinoma].
Hoefer M; Schmidt S; Welter J; Kirsch CM; Ukena D; Sybrecht GW
Pneumologie; 1998 Feb; 52(2):106-12. PubMed ID: 9557059
[TBL] [Abstract][Full Text] [Related]
3. 111In-Pentetreotide (OctreoScan) scintigraphy in the staging of small-cell lung cancer: its accuracy and prognostic significance.
Genestreti G; Bongiovanni A; Burgio MA; Burgio SL; Musto A; Rossi A; Monti M; Scarpi E; Ulivi P; Bravaccini S; Dubini A; Matteucci F; Gavelli G
Nucl Med Commun; 2015 Feb; 36(2):135-42. PubMed ID: 25321157
[TBL] [Abstract][Full Text] [Related]
4. Scintigraphic imaging of small-cell lung cancer with [111In]pentetreotide, a radiolabelled somatostatin analogue.
O'Byrne KJ; Ennis JT; Freyne PJ; Clancy LJ; Prichard JS; Carney DN
Br J Cancer; 1994 Apr; 69(4):762-6. PubMed ID: 7908220
[TBL] [Abstract][Full Text] [Related]
5. Somatostatin receptor scintigraphy in the staging of small cell lung cancer.
Bohuslavizki KH; Brenner W; Günther M; Eberhardt JU; Jahn N; Tinnemeyer S; Wolf H; Sippel C; Clausen M; Gatzemeier U; Henze E
Nucl Med Commun; 1996 Mar; 17(3):191-6. PubMed ID: 8692484
[TBL] [Abstract][Full Text] [Related]
6. 111In-DTPA-D-Phe-1-octreotide scintigraphy of small cell lung cancer.
Bombardieri E; Chiti A; Crippa F; Seregni E; Cataldo I; Maffioli L; Soresi E
Q J Nucl Med; 1995 Dec; 39(4 Suppl 1):104-7. PubMed ID: 9002763
[TBL] [Abstract][Full Text] [Related]
7. Somatostatin receptor imaging in small cell lung cancer.
Berenger N; Moretti JL; Boaziz C; Vigneron N; Morere JF; Breau JL
Eur J Cancer; 1996 Jul; 32A(8):1429-31. PubMed ID: 8869110
[TBL] [Abstract][Full Text] [Related]
8. Somatostatin receptor scintigraphy in small-cell lung cancer: results of a multicenter study.
Reisinger I; Bohuslavitzki KH; Brenner W; Braune S; Dittrich I; Geide A; Kettner B; Otto HJ; Schmidt S; Munz DL
J Nucl Med; 1998 Feb; 39(2):224-7. PubMed ID: 9476922
[TBL] [Abstract][Full Text] [Related]
9. 111In-octreotide scintigraphy in small cell lung cancer.
Semprebene A; Ferraironi A; Franciotti G; Venturo I; Giunta S; Lopez M; Maini CL
Q J Nucl Med; 1995 Dec; 39(4 Suppl 1):108-10. PubMed ID: 9002764
[TBL] [Abstract][Full Text] [Related]
10. Somatostatin receptor imaging of small cell lung cancer (SCLC) by means of 111In-DTPA octreotide scintigraphy.
Bombardieri E; Crippa F; Cataldo I; Chiti A; Seregni E; Soresi E; Boffi R; Invernizzi G; Buraggi GL
Eur J Cancer; 1995; 31A(2):184-8. PubMed ID: 7718323
[TBL] [Abstract][Full Text] [Related]
11. The value of octreotide scintigraphy in patients with lung cancer.
Kwekkeboom DJ; Kho GS; Lamberts SW; Reubi JC; Laissue JA; Krenning EP
Eur J Nucl Med; 1994 Oct; 21(10):1106-13. PubMed ID: 7828621
[TBL] [Abstract][Full Text] [Related]
12. In-111 octreotide imaging in staging of small cell lung cancer.
Hochstenbag MM; Heidendal GA; Wouters EF; ten Velde GP
Clin Nucl Med; 1997 Dec; 22(12):811-6. PubMed ID: 9408640
[TBL] [Abstract][Full Text] [Related]
13. The International Association for the Study of Lung Cancer lung cancer staging project: proposals regarding the clinical staging of small cell lung cancer in the forthcoming (seventh) edition of the tumor, node, metastasis classification for lung cancer.
Shepherd FA; Crowley J; Van Houtte P; Postmus PE; Carney D; Chansky K; Shaikh Z; Goldstraw P;
J Thorac Oncol; 2007 Dec; 2(12):1067-77. PubMed ID: 18090577
[TBL] [Abstract][Full Text] [Related]
14. Imaging and staging of small-cell lung cancer: is there a future role for octreotide scintigraphy?
Stokkel MP; Kwa BM; Pauwels EK
Br J Clin Pract; 1995; 49(5):235-8. PubMed ID: 7492457
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of indium-111 pentetreotide somatostatin receptor scintigraphy to detect recurrent thyroid carcinoma in patients with negative radioiodine scintigraphy.
Valli N; Catargi B; Ronci N; Leccia F; Guyot M; Roger P; Ducassou D; Tabarin A
Thyroid; 1999 Jun; 9(6):583-9. PubMed ID: 10411121
[TBL] [Abstract][Full Text] [Related]
16. Targeted radiotherapy for small cell lung cancer using 90Yttrium-DOTATOC, an Yttrium-labelled somatostatin analogue: a pilot trial.
Pless M; Waldherr C; Maecke H; Buitrago C; Herrmann R; Mueller-Brand J
Lung Cancer; 2004 Sep; 45(3):365-71. PubMed ID: 15301877
[TBL] [Abstract][Full Text] [Related]
17. 111In-pentetreotide scintigraphy in the post-thyroidectomy follow-up of patients with medullary thyroid carcinoma.
Celentano L; Sullo P; Klain M; Lupoli G; Cascone E; Salvatore M
Q J Nucl Med; 1995 Dec; 39(4 Suppl 1):131-3. PubMed ID: 9002771
[TBL] [Abstract][Full Text] [Related]
18. Staging non-small cell lung cancer with whole-body PET.
Marom EM; McAdams HP; Erasmus JJ; Goodman PC; Culhane DK; Coleman RE; Herndon JE; Patz EF
Radiology; 1999 Sep; 212(3):803-9. PubMed ID: 10478250
[TBL] [Abstract][Full Text] [Related]
19. Radiolabelled somatostatin analogue scintigraphy in oncology.
O'Byrne KJ; Carney DN
Anticancer Drugs; 1996 Jan; 7 Suppl 1():33-44. PubMed ID: 8822083
[TBL] [Abstract][Full Text] [Related]
20. Positron emission tomography in limited-stage small-cell lung cancer: a prospective study.
Bradley JD; Dehdashti F; Mintun MA; Govindan R; Trinkaus K; Siegel BA
J Clin Oncol; 2004 Aug; 22(16):3248-54. PubMed ID: 15310768
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
